ID   ZN148_HUMAN             Reviewed;         794 AA.
AC   Q9UQR1; D3DN27; O00389; O43591; Q58EY5; Q6PJ98;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   28-JUN-2023, entry version 201.
DE   RecName: Full=Zinc finger protein 148;
DE   AltName: Full=Transcription factor ZBP-89;
DE   AltName: Full=Zinc finger DNA-binding protein 89;
GN   Name=ZNF148; Synonyms=ZBP89;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9457682; DOI=10.1007/s003359900711;
RA   Law D.J., Tarle S.A., Merchant J.L.;
RT   "The human ZBP-89 homolog, located at chromosome 3q21, represses gastrin
RT   gene expression.";
RL   Mamm. Genome 9:165-167(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10359087; DOI=10.1016/s0014-5793(99)00509-8;
RA   Ye S., Whatling C., Watkins H., Henney A.;
RT   "Human stromelysin gene promoter activity is modulated by transcription
RT   factor ZBP-89.";
RL   FEBS Lett. 450:268-272(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=B-cell, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 262-665.
RA   Law D.J., Chen X.N., Korenberg J.R., Mortensen E.R., Merchant J.L.;
RT   "The growth-regulating transcription factor ZBP-89 is located at human
RT   chromosome 3q21 and mouse chromosome 8B1.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH HNRNPDL.
RX   PubMed=15190078; DOI=10.1074/jbc.m403160200;
RA   Boopathi E., Lenka N., Prabu S.K., Fang J.-K., Wilkinson F., Atchison M.,
RA   Giallongo A., Avadhani N.G.;
RT   "Regulation of murine cytochrome c oxidase Vb gene expression during
RT   myogenesis: YY-1 and heterogeneous nuclear ribonucleoprotein D-like protein
RT   (JKTBP1) reciprocally regulate transcription activity by physical
RT   interaction with the BERF-1/ZBP-89 factor.";
RL   J. Biol. Chem. 279:35242-35254(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-194; SER-250; SER-306;
RP   SER-412 AND SER-784, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-784, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-607, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-665 AND SER-784, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-412 AND SER-665, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-412, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-356, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-356, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-356, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [20]
RP   INVOLVEMENT IN GDACCF.
RX   PubMed=27964749; DOI=10.1186/s13073-016-0386-9;
RA   Stevens S.J., van Essen A.J., van Ravenswaaij C.M., Elias A.F., Haven J.A.,
RA   Lelieveld S.H., Pfundt R., Nillesen W.M., Yntema H.G., van Roozendaal K.,
RA   Stegmann A.P., Gilissen C., Brunner H.G.;
RT   "Truncating de novo mutations in the Krueppel-type zinc-finger gene ZNF148
RT   in patients with corpus callosum defects, developmental delay, short
RT   stature, and dysmorphisms.";
RL   Genome Med. 8:131-131(2016).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-88; LYS-115; LYS-132;
RP   LYS-291; LYS-308; LYS-356; LYS-402; LYS-421 AND LYS-424, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in transcriptional regulation. Represses the
CC       transcription of a number of genes including gastrin, stromelysin and
CC       enolase. Binds to the G-rich box in the enhancer region of these genes.
CC   -!- SUBUNIT: Interacts with HNRNPDL (PubMed:15190078). Interacts with the
CC       5FMC complex; the interaction requires association with CHTOP.
CC       Interacts with CAVIN1 (By similarity). {ECO:0000250|UniProtKB:Q61624,
CC       ECO:0000269|PubMed:15190078}.
CC   -!- INTERACTION:
CC       Q9UQR1; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-2688184, EBI-739624;
CC       Q9UQR1; Q05D60: DEUP1; NbExp=3; IntAct=EBI-2688184, EBI-748597;
CC       Q9UQR1; B7ZLH0: FAM22F; NbExp=3; IntAct=EBI-2688184, EBI-10220102;
CC       Q9UQR1; O76003: GLRX3; NbExp=3; IntAct=EBI-2688184, EBI-374781;
CC       Q9UQR1; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-2688184, EBI-739467;
CC       Q9UQR1; Q15323: KRT31; NbExp=3; IntAct=EBI-2688184, EBI-948001;
CC       Q9UQR1; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-2688184, EBI-747107;
CC       Q9UQR1; Q9UDY6: TRIM10; NbExp=3; IntAct=EBI-2688184, EBI-6427325;
CC       Q9UQR1-2; Q96MT8-3: CEP63; NbExp=3; IntAct=EBI-11742222, EBI-11522539;
CC       Q9UQR1-2; B7ZLH0: FAM22F; NbExp=3; IntAct=EBI-11742222, EBI-10220102;
CC       Q9UQR1-2; Q9H8Y8: GORASP2; NbExp=5; IntAct=EBI-11742222, EBI-739467;
CC       Q9UQR1-2; Q6IE81-3: JADE1; NbExp=3; IntAct=EBI-11742222, EBI-12120084;
CC       Q9UQR1-2; O76011: KRT34; NbExp=3; IntAct=EBI-11742222, EBI-1047093;
CC       Q9UQR1-2; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11742222, EBI-739832;
CC       Q9UQR1-2; Q99471: PFDN5; NbExp=3; IntAct=EBI-11742222, EBI-357275;
CC       Q9UQR1-2; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-11742222, EBI-949255;
CC       Q9UQR1-2; Q8ND90: PNMA1; NbExp=3; IntAct=EBI-11742222, EBI-302345;
CC       Q9UQR1-2; P78424: POU6F2; NbExp=3; IntAct=EBI-11742222, EBI-12029004;
CC       Q9UQR1-2; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-11742222, EBI-11975223;
CC       Q9UQR1-2; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-11742222, EBI-12030590;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UQR1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UQR1-2; Sequence=VSP_055938, VSP_055939;
CC   -!- PTM: Sumoylated with SUMO2. Desumoylated by SENP3, resulting in the
CC       stimulation of transcription of its target genes (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Global developmental delay, absent or hypoplastic corpus
CC       callosum, and dysmorphic facies (GDACCF) [MIM:617260]: An autosomal
CC       dominant syndrome characterized by underdevelopment of the corpus
CC       callosum, mild to moderate developmental delay and intellectual
CC       disability, variable microcephaly or mild macrocephaly, short stature,
CC       feeding problems, facial dysmorphisms, and cardiac and renal
CC       malformations. {ECO:0000269|PubMed:27964749}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF039019; AAC39926.1; -; mRNA.
DR   EMBL; AJ236885; CAA15422.1; -; mRNA.
DR   EMBL; AC108688; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79394.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79395.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79396.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79398.1; -; Genomic_DNA.
DR   EMBL; BC018971; AAH18971.1; -; mRNA.
DR   EMBL; BC050260; AAH50260.1; -; mRNA.
DR   EMBL; U96633; AAB57692.1; -; Genomic_DNA.
DR   CCDS; CCDS3031.1; -. [Q9UQR1-1]
DR   RefSeq; NP_001335353.1; NM_001348424.1. [Q9UQR1-1]
DR   RefSeq; NP_001335354.1; NM_001348425.1. [Q9UQR1-1]
DR   RefSeq; NP_001335355.1; NM_001348426.1. [Q9UQR1-1]
DR   RefSeq; NP_001335356.1; NM_001348427.1. [Q9UQR1-1]
DR   RefSeq; NP_001335357.1; NM_001348428.1. [Q9UQR1-1]
DR   RefSeq; NP_001335358.1; NM_001348429.1. [Q9UQR1-1]
DR   RefSeq; NP_001335359.1; NM_001348430.1. [Q9UQR1-1]
DR   RefSeq; NP_001335360.1; NM_001348431.1. [Q9UQR1-1]
DR   RefSeq; NP_001335361.1; NM_001348432.1. [Q9UQR1-1]
DR   RefSeq; NP_001335362.1; NM_001348433.1. [Q9UQR1-1]
DR   RefSeq; NP_068799.2; NM_021964.2. [Q9UQR1-1]
DR   AlphaFoldDB; Q9UQR1; -.
DR   SMR; Q9UQR1; -.
DR   BioGRID; 113501; 122.
DR   IntAct; Q9UQR1; 65.
DR   MINT; Q9UQR1; -.
DR   STRING; 9606.ENSP00000353863; -.
DR   GlyCosmos; Q9UQR1; 6 sites, 1 glycan.
DR   GlyGen; Q9UQR1; 8 sites, 1 O-linked glycan (8 sites).
DR   iPTMnet; Q9UQR1; -.
DR   PhosphoSitePlus; Q9UQR1; -.
DR   SwissPalm; Q9UQR1; -.
DR   BioMuta; ZNF148; -.
DR   DMDM; 12643385; -.
DR   EPD; Q9UQR1; -.
DR   jPOST; Q9UQR1; -.
DR   MassIVE; Q9UQR1; -.
DR   MaxQB; Q9UQR1; -.
DR   PaxDb; Q9UQR1; -.
DR   PeptideAtlas; Q9UQR1; -.
DR   ProteomicsDB; 67196; -.
DR   ProteomicsDB; 85574; -. [Q9UQR1-1]
DR   Antibodypedia; 901; 272 antibodies from 29 providers.
DR   DNASU; 7707; -.
DR   Ensembl; ENST00000360647.9; ENSP00000353863.4; ENSG00000163848.21. [Q9UQR1-1]
DR   Ensembl; ENST00000471196.2; ENSP00000420038.2; ENSG00000163848.21. [Q9UQR1-1]
DR   Ensembl; ENST00000484491.5; ENSP00000420335.1; ENSG00000163848.21. [Q9UQR1-1]
DR   Ensembl; ENST00000485866.5; ENSP00000420448.1; ENSG00000163848.21. [Q9UQR1-1]
DR   Ensembl; ENST00000492394.5; ENSP00000419322.1; ENSG00000163848.21. [Q9UQR1-1]
DR   Ensembl; ENST00000700044.1; ENSP00000514760.1; ENSG00000163848.21. [Q9UQR1-1]
DR   GeneID; 7707; -.
DR   KEGG; hsa:7707; -.
DR   MANE-Select; ENST00000360647.9; ENSP00000353863.4; NM_021964.3; NP_068799.2.
DR   UCSC; uc003ehx.5; human. [Q9UQR1-1]
DR   AGR; HGNC:12933; -.
DR   CTD; 7707; -.
DR   DisGeNET; 7707; -.
DR   GeneCards; ZNF148; -.
DR   HGNC; HGNC:12933; ZNF148.
DR   HPA; ENSG00000163848; Low tissue specificity.
DR   MalaCards; ZNF148; -.
DR   MIM; 601897; gene.
DR   MIM; 617260; phenotype.
DR   neXtProt; NX_Q9UQR1; -.
DR   OpenTargets; ENSG00000163848; -.
DR   PharmGKB; PA37520; -.
DR   VEuPathDB; HostDB:ENSG00000163848; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000157406; -.
DR   HOGENOM; CLU_025987_1_0_1; -.
DR   InParanoid; Q9UQR1; -.
DR   OMA; FEQNFKS; -.
DR   OrthoDB; 5318724at2759; -.
DR   PhylomeDB; Q9UQR1; -.
DR   TreeFam; TF331779; -.
DR   PathwayCommons; Q9UQR1; -.
DR   SignaLink; Q9UQR1; -.
DR   SIGNOR; Q9UQR1; -.
DR   BioGRID-ORCS; 7707; 53 hits in 1195 CRISPR screens.
DR   ChiTaRS; ZNF148; human.
DR   GeneWiki; ZNF148; -.
DR   GenomeRNAi; 7707; -.
DR   Pharos; Q9UQR1; Tbio.
DR   PRO; PR:Q9UQR1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UQR1; protein.
DR   Bgee; ENSG00000163848; Expressed in caput epididymis and 213 other tissues.
DR   ExpressionAtlas; Q9UQR1; baseline and differential.
DR   Genevisible; Q9UQR1; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0007276; P:gamete generation; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0065003; P:protein-containing complex assembly; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 4.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24394; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24394:SF23; ZINC FINGER PROTEIN 281A; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 4.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; DNA-binding; Dwarfism;
KW   Intellectual disability; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..794
FT                   /note="Zinc finger protein 148"
FT                   /id="PRO_0000047427"
FT   ZN_FING         171..193
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         199..221
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         227..249
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         255..278
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          298..336
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          574..596
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..336
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61624"
FT   MOD_RES         194
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61624"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         607
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         784
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        88
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        115
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        132
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        291
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        308
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        356
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        356
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        402
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..205
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055938"
FT   VAR_SEQ         233..690
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055939"
FT   CONFLICT        287
FT                   /note="R -> T (in Ref. 2; CAA15422)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="L -> V (in Ref. 2; CAA15422)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="E -> K (in Ref. 6; AAB57692)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        495
FT                   /note="A -> R (in Ref. 2; CAA15422)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        616
FT                   /note="T -> N (in Ref. 6; AAB57692)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   794 AA;  88976 MW;  50413723459EBD1F CRC64;
     MNIDDKLEGL FLKCGGIDEM QSSRTMVVMG GVSGQSTVSG ELQDSVLQDR SMPHQEILAA
     DEVLQESEMR QQDMISHDEL MVHEETVKND EEQMETHERL PQGLQYALNV PISVKQEITF
     TDVSEQLMRD KKQIREPVDL QKKKKRKQRS PAKILTINED GSLGLKTPKS HVCEHCNAAF
     RTNYHLQRHV FIHTGEKPFQ CSQCDMRFIQ KYLLQRHEKI HTGEKPFRCD ECGMRFIQKY
     HMERHKRTHS GEKPYQCEYC LQYFSRTDRV LKHKRMCHEN HDKKLNRCAI KGGLLTSEED
     SGFSTSPKDN SLPKKKRQKT EKKSSGMDKE SALDKSDLKK DKNDYLPLYS SSTKVKDEYM
     VAEYAVEMPH SSVGGSHLED ASGEIHPPKL VLKKINSKRS LKQPLEQNQT ISPLSTYEES
     KVSKYAFELV DKQALLDSEG NADIDQVDNL QEGPSKPVHS STNYDDAMQF LKKKRYLQAA
     SNNSREYALN VGTIASQPSV TQAAVASVID ESTTASILES QALNVEIKSN HDKNVIPDEV
     LQTLLDHYSH KANGQHEISF SVADTEVTSS ISINSSEVPE VTPSENVGSS SQASSSDKAN
     MLQEYSKFLQ QALDRTSQND AYLNSPSLNF VTDNQTLPNQ PAFSSIDKQV YATMPINSFR
     SGMNSPLRTT PDKSHFGLIV GDSQHSFPFS GDETNHASAT STQDFLDQVT SQKKAEAQPV
     HQAYQMSSFE QPFRAPYHGS RAGIATQFST ANGQVNLRGP GTSAEFSEFP LVNVNDNRAG
     MTSSPDATTG QTFG
//
